ALEC Latest Press Releases

-- May 7, 2026 --

Alector Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- April 29, 2026 --

Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer's Disease Following Interim Futility Analysis Globe Newswire 4:05 PM

-- February 25, 2026 --

Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:10 PM

-- February 24, 2026 --

Alector to Participate in the TD Cowen 46th Annual Health Care Conference Globe Newswire 8:00 AM

-- January 29, 2026 --

INVESTOR ALERT: Levi & Korsinsky is Investigating Alec Stock After its Phase 3 INFRONT-3 Clinical Trial Misses Co-Primary Endpoint PRNewswire 6:06 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software